Related references
Note: Only part of the references are listed.What is pre-fibrotic myelofibrosis and how should it be managed in 2018?
Natalia Curto-Garcia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Prefibrotic myelofibrosis: treatment algorithm 2018
Guido Finazzi et al.
BLOOD CANCER JOURNAL (2018)
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria
Elisa Rumi et al.
ONCOTARGET (2017)
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease
Georg Jeryczynski et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis
Paola Guglielmelli et al.
BLOOD (2017)
Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
H. Gisslinger et al.
LEUKEMIA (2016)
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
Juergen Thiele et al.
BLOOD (2011)
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
Tiziano Barbui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Share Paper
